Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities

A. Skálová, A. Agaimy, M. Bradova, VV. Poorten, E. Hanna, O. Guntinas-Lichius, A. Franchi, H. Hellquist, RHW. Simpson, F. Lopéz, S. Nuyts, C. Chiesa-Estomba, SP. Ng, A. Homma, Y. Teng, I. Leivo, A. Ferlito

. 2024 ; 484 (6) : 885-900. [pub] 20240316

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013748
E-zdroje Online Plný text

NLK ProQuest Central od 2003-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2003-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2003-01-01 do Před 1 rokem

Classification of tumors of the head and neck has evolved in recent decades including a widespread application of molecular testing in tumors of the sinonasal tract, salivary glands, and soft tissues with a predilection for the head and neck. The availability of new molecular techniques has allowed for the definition of multiple novel tumor types unique to head and neck sites. Moreover, an expanding spectrum of immunohistochemical markers specific to genetic alterations facilitates rapid identification of diagnostic molecular abnormalities. As such, it is currently possible for head and neck pathologists to benefit from a molecularly defined tumor classification while making diagnoses that are still based largely on histopathology and immunohistochemistry. This review covers the principal molecular alterations in sinonasal malignancies, such as alterations in DEK, AFF2, NUTM1, IDH1-2, and SWI/SNF genes in particular, that are important from a practical standpoint for diagnosis, prognosis, and prediction of response to treatment.

Bioptic Laboratory Ltd Pilsen Czech Republic

Coordinator of the International Head and Neck Scientific Group Padua Italy

Department of Anatomical Pathology University of Calgary Calgary AB Canada

Department of Head and Neck Surgery The University of Texas MD Anderson Cancer Center Houston TX USA

Department of Hematology and Medical Oncology Winship Cancer Institute Emory University School of Medicine Atlanta GA USA

Department of Oncology Section Head and Neck Oncology Leuven Cancer Institute KU Leuven Louvain Belgium

Department of Otolaryngology Head and Neck Surgery Faculty of Medicine Graduate School of Medicine Hokkaido University Hokkaido Japan

Department of Otolaryngology ISPA IUOPA CIBERONC Hospital Universitario Central de Asturias University of Oviedo Oviedo Spain

Department of Otorhinolaryngology Head and Neck Surgery Hospital Universitario Donostia Donostia San Sebastian Guipuzkoa Basque Country Spain

Department of Otorhinolaryngology Head and Neck Surgery Leuven Cancer Institute University Hospitals Leuven 3000 Louvain Belgium

Department of Otorhinolaryngology Jena University Hospital Jena Germany

Department of Pathology Turku University Hospital Turku Finland

Department of Radiation Oncology Leuven Cancer Institute University Hospitals Leuven 3000 Louvain Belgium

Department of Radiation Oncology Olivia Newton John Cancer Wellness and Research Centre Austin Health Melbourne Australia

Department of Translational Research School of Medicine University of Pisa Pisa Italy

Faculty of Medicine and Biomedical Sciences University of Algarve Faro Portugal

Institute of Biomedicine Pathology University of Turku Turku Finland

Institute of Pathology University Hospital Erlangen Friedrich Alexander University Erlangen Nürnberg Erlangen Germany

Laboratory of Experimental Radiotherapy Department of Oncology Leuven Cancer Institute University Hospitals Leuven 3000 Louvain Belgium

Sikl's Department of Pathology Faculty of Medicine in Pilsen Charles University E Benese 13 305 99 Pilsen Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013748
003      
CZ-PrNML
005      
20240905133555.0
007      
ta
008      
240725s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00428-024-03775-y $2 doi
035    __
$a (PubMed)38491228
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Skálová, Alena $u Sikl's Department of Pathology, Faculty of Medicine in Pilsen, Charles University, E. Benese 13, 305 99, Pilsen, Czech Republic. skalova@biopticka.cz $u Bioptic Laboratory, Ltd., Pilsen, Czech Republic. skalova@biopticka.cz
245    10
$a Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities / $c A. Skálová, A. Agaimy, M. Bradova, VV. Poorten, E. Hanna, O. Guntinas-Lichius, A. Franchi, H. Hellquist, RHW. Simpson, F. Lopéz, S. Nuyts, C. Chiesa-Estomba, SP. Ng, A. Homma, Y. Teng, I. Leivo, A. Ferlito
520    9_
$a Classification of tumors of the head and neck has evolved in recent decades including a widespread application of molecular testing in tumors of the sinonasal tract, salivary glands, and soft tissues with a predilection for the head and neck. The availability of new molecular techniques has allowed for the definition of multiple novel tumor types unique to head and neck sites. Moreover, an expanding spectrum of immunohistochemical markers specific to genetic alterations facilitates rapid identification of diagnostic molecular abnormalities. As such, it is currently possible for head and neck pathologists to benefit from a molecularly defined tumor classification while making diagnoses that are still based largely on histopathology and immunohistochemistry. This review covers the principal molecular alterations in sinonasal malignancies, such as alterations in DEK, AFF2, NUTM1, IDH1-2, and SWI/SNF genes in particular, that are important from a practical standpoint for diagnosis, prognosis, and prediction of response to treatment.
650    _2
$a lidé $7 D006801
650    12
$a nádory vedlejších dutin nosních $x patologie $x genetika $x klasifikace $x diagnóza $7 D010255
650    12
$a nádorové biomarkery $x genetika $x analýza $7 D014408
650    _2
$a Světová zdravotnická organizace $7 D014944
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Agaimy, Abbas $u Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
700    1_
$a Bradova, Martina $u Sikl's Department of Pathology, Faculty of Medicine in Pilsen, Charles University, E. Benese 13, 305 99, Pilsen, Czech Republic $u Bioptic Laboratory, Ltd., Pilsen, Czech Republic
700    1_
$a Poorten, Vincent Vander $u Department of Otorhinolaryngology-Head and Neck Surgery, Leuven Cancer Institute, University Hospitals Leuven, 3000, Louvain, Belgium $u Department of Oncology, Section Head and Neck Oncology, Leuven Cancer Institute, KU Leuven, Louvain, Belgium
700    1_
$a Hanna, Ehab $u Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
700    1_
$a Guntinas-Lichius, Orlando $u Department of Otorhinolaryngology, Jena University Hospital, Jena, Germany
700    1_
$a Franchi, Alessandro $u Department of Translational Research, School of Medicine, University of Pisa, Pisa, Italy
700    1_
$a Hellquist, Henrik $u Faculty of Medicine and Biomedical Sciences (FMCB), Biomedical Center Research Institute (ABC-RI), University of Algarve, Faro, Portugal
700    1_
$a Simpson, Roderick H W $u Department of Anatomical Pathology, University of Calgary, Calgary, AB, Canada
700    1_
$a Lopéz, Fernando $u Department of Otolaryngology, ISPA, IUOPA, CIBERONC, Hospital Universitario Central de Asturias, University of Oviedo, Oviedo, Spain
700    1_
$a Nuyts, Sandra $u Laboratory of Experimental Radiotherapy, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000, Louvain, Belgium $u Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000, Louvain, Belgium
700    1_
$a Chiesa-Estomba, Carlos $u Department of Otorhinolaryngology-Head and Neck Surgery, Hospital Universitario Donostia, Donostia-San Sebastian, Guipuzkoa-Basque Country, Spain
700    1_
$a Ng, Sweet Ping $u Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Melbourne, Australia
700    1_
$a Homma, Akihiro $u Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
700    1_
$a Teng, Yong $u Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
700    1_
$a Leivo, Ilmo $u Institute of Biomedicine, Pathology, University of Turku, Turku, Finland $u Department of Pathology, Turku University Hospital, Turku, Finland
700    1_
$a Ferlito, Alfio $u Coordinator of the International Head and Neck Scientific Group, Padua, Italy
773    0_
$w MED00004660 $t Virchows Archiv $x 1432-2307 $g Roč. 484, č. 6 (2024), s. 885-900
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38491228 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133549 $b ABA008
999    __
$a ok $b bmc $g 2143510 $s 1225614
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 484 $c 6 $d 885-900 $e 20240316 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...